Department of Transplant Surgery, Western Australian Kidney and Liver Transplant Surgery, Sir Charles Gairdner Hospital, Perth, WA, Australia.
Public Health, Sydney School of Public Health, University of Sydney, Sydney, NSW, Australia.
Transplantation. 2024 Oct 1;108(10):2117-2126. doi: 10.1097/TP.0000000000005022. Epub 2024 Sep 24.
The number of donors from donation after circulatory determination of death (DCDD) has increased by at least 4-fold over the past decade. This study evaluated the association between the antecedent cardiac arrest status of controlled DCDD donors and the risk of delayed graft function (DGF).
Using data from the Australia and New Zealand Dialysis and Transplant, the associations between antecedent cardiac arrest status of DCDD donors before withdrawal of cardiorespiratory support, DGF, posttransplant estimated glomerular filtration rate (eGFR), and allograft loss were examined using adjusted logistic, linear mixed modeling, and cox regression, respectively. Among donors who experienced cardiac arrest, we evaluated the association between duration and unwitnessed status of arrest and DGF.
A total of 1173 kidney transplant recipients received DCDD kidneys from 646 donors in Australia between 2014 and 2019. Of these, 335 DCDD had antecedent cardiac arrest. Compared with recipients of kidneys from donors without antecedent cardiac arrest, the adjusted odds ratio (95% confidence interval) for DGF was 0.85 (0.65-1.11) among those with kidneys from donors with cardiac arrest. There was no association between antecedent cardiac arrest and posttransplant eGFR or allograft loss. The duration of cardiac arrest and unwitnessed status were not associated with DGF.
This focused analysis in an Australian population showed that the allograft outcomes were similar whether DCDD donors had experienced a prior cardiac arrest, with no associations between duration or unwitnessed status of arrest and risk of DGF. This study thus provides important reassurance to transplant programs and the patients they counsel, to accept kidneys from donors through the DCDD pathway irrespective of a prior cardiac arrest.
在过去的十年中,通过循环判定死亡后捐献(DCDD)的捐献者数量至少增加了 4 倍。本研究评估了控制 DCDD 供体心脏骤停前状态与延迟移植物功能障碍(DGF)风险之间的关系。
利用澳大利亚和新西兰透析和移植的数据,分别使用调整后的逻辑回归、线性混合模型和 Cox 回归,研究了 DCDD 供体在停止心肺支持前心脏骤停状态、DGF、移植后估计肾小球滤过率(eGFR)和移植物丢失之间的关系。在经历心脏骤停的供体中,我们评估了心脏骤停持续时间和未目击状态与 DGF 的关系。
在 2014 年至 2019 年间,共有 1173 名接受肾移植的患者从澳大利亚的 646 名供体中接受了 DCDD 肾脏。其中,335 名 DCDD 有心脏骤停的既往史。与接受无心脏骤停既往史供体肾脏的患者相比,心脏骤停供体肾脏的患者发生 DGF 的调整比值比(95%置信区间)为 0.85(0.65-1.11)。心脏骤停与移植后 eGFR 或移植物丢失之间无关联。心脏骤停的持续时间和未目击状态与 DGF 无关。
本研究对澳大利亚人群的集中分析表明,无论 DCDD 供体是否经历过先前的心脏骤停,同种异体移植物的结局相似,心脏骤停的持续时间或未目击状态与 DGF 的风险之间没有关联。因此,该研究为移植项目及其咨询的患者提供了重要保证,即无论供体是否有过心脏骤停,都可以通过 DCDD 途径接受肾脏。